APP and Alzheimer disease: In this study we engineered hESC to express reduced levels of KLC1 using small hairpin RNA (shRNA) targeted to KLC1 and examined whether suppression of endogenous KLC1 impairs human neural differentiation or endogenous human APP metabolism, which is implicated in AD.